Format

Send to

Choose Destination
J Clin Psychiatry. 2018 Jan/Feb;79(1). pii: 17l11824. doi: 10.4088/JCP.17l11824.

Effects of Rapastinel (Formerly GLYX-13) on Serum Brain-Derived Neurotrophic Factor in Obsessive-Compulsive Disorder.

Author information

1
Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California, USA.
2
Analytical Psychopharmacology Laboratory, Nathan Kline Institute, Research Foundation for Mental Hygiene of New York State, Orangeburg, New York, USA.
3
Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, New York, USA.
4
New York State Psychiatric Institute, New York, New York, USA.
5
Aptinyx, Inc, Evanston, Illinois, USA.
6
The Falk Center for Molecular Therapeutics, Department of Biomedical Engineering, McCormick School of Engineering and Applied Sciences, Northwestern University, Evanston, Illinois, USA.
7
Department of Psychiatry, Weill Cornell Medical College, New York, New York, USA.
8
carolynrodriguez@stanford.edu.
9
Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA.
PMID:
29505186
DOI:
10.4088/JCP.17l11824
Free full text

Supplemental Content

Full text links

Icon for Physicians Postgraduate Press, Inc.
Loading ...
Support Center